Skip to main content

Table 4 Infusion reactions leading to withdrawal from study

From: Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients

Patient ID (age)

Number infusions

Reactions

Treatment/outcome

210 (50 y)

2

Nausea, dyspnea, hypoxemia, tachycardia, diaphoresis, hypotension, systemic rash

IV fluids, O2, epinephrine, diphenhydramine; hospitalized overnight. All symptoms resolved.

213 (43 y)

3

Chills, nausea, chest tightness, systemic urticaria

Infusion slowed, acetaminophen, diphenhydramine. All symptoms resolved.

219 (67 y)

<1

Syncope

Infusion stopped. All symptoms resolved.

237 (25 y)

3

Chest tightness, dyspnea, flushing, tachycardia

Infusion stopped; diphenhydramine. All symptoms resolved.

241 (70 y)

2

Pruritus, chest tightness, hypotension, hypoxemia

Infusion stopped; IV fluids, O2, diphenhydramine. All symptoms resolved.